Cowen And Company, LLC Allakos Inc. Call Options Transaction History

Cowen And Company, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$76.53 - $110.43 $3.54 Million - $5.1 Million	-46,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$85.37 - $114.1 $3.94 Million - $5.27 Million	46,200 New	46,200 $109,000
Q4 2019 Feb 11, 2020	SELL	$66.49 - $137.73 $1.16 Million - $2.41 Million	-17,500 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$31.0 - $89.73 $542,500 - $1.57 Million	17,500 New	17,500 $457,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.